Shinil Pharmaceutical Targets Price-to-Book Ratio of 3 by 2029

Bitget2026/10/22 07:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Shinil Pharmaceutical targets a price-to-book ratio of 3 times by 2029 under its corporate value enhancement plan adopted October 22, 2026.
The plan aims to improve net profit margins and total asset turnover while strengthening growth expectations.
Regular investor relations materials will support expanded communication with shareholders and market participants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shinil Pharmaceutical co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261022900507), on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Shinil Pharmaceutical Targets Price-to-Book Ratio of 3 by 2029

You may also like

Crypto prices